01 1Almelo
01 1PREGABALIN USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-09-17
Pay. Date : 2020-07-27
DMF Number : 33522
Submission : 2019-03-19
Status : Active
Type : II
20
Almelo Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PREGABALIN USP, with a corresponding US DMF Number 33522.
Remarkably, this DMF maintains an Active status since its submission on March 19, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 17, 2020, and payment made on July 27, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
